eMedevents

Activity Objectives:

What the Future Holds for NASH: An Augmented Reality Look into Disease Staging and Targeted Therapies is organized by CME Outfitters, LLC. 

Symposium Date/Time: Sunday, November 10, 2019
Credit Expiration Date: Tuesday, November 10, 2020

Target Audience:
Hepatologists, gastroenterologists, endocrinologists, diabetologists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists.

Credit Information:
CME Credit (Physicians):

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

CPE Credit (Pharmacists):
CME Outfitters, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15) CEUs).

ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. 

Statement of Need:
Given the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and the societal and economic burden of its aggressive subtype, non-alcoholic steatohepatitis (NASH), it is important that hepatologists and gastroenterologists are equipped with the latest tools to diagnose NASH. While there are currently no approved therapies for the treatment of NASH, several targeted therapies are being investigated in clinical trials, with high probability of being approved in the near future. Hence, it is imperative that hepatologists and gastroenterologists have up to date knowledge regarding the latest clinical data on NASH therapies.

This CME Outfitters symposium will feature expert faculty integrating augmented reality (AR) to discuss pathways, therapeutic targets, and disease progression providing the learners with the best visual experience to enable them to integrate the latest tools for diagnosis and management of patients with NASH.

This activity offers CE credit for:
• Physicians (CME)
• Nurses (CNE)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Describe the role of immune, inflammatory, and metabolic pathways in the pathogenesis of NASH.
• Select appropriate non-invasive and invasive modalities for the identification of advanced fibrosis in patients with NAFLD.
• Evaluate the efficacy of emerging therapies for improving fibrosis in patients with NASH.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Describe the role of immune, inflammatory, and metabolic pathways in the pathogenesis of NASH.
• Determine appropriate non-invasive and invasive modalities for the identification of advanced fibrosis in patients with NAFLD.
• Evaluate the efficacy of emerging therapies for improving fibrosis in patients with NASH.

Intended Audience

Gastroenterology

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

CME Outfitters, LLC

View Organizer Details

Help

614.328.4500